80 results
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
Hypereosinophilic Syndrome • Clinically ... suspect underlying hematologic ... Diagnosis and Treatment ... Syndrome #HES #Hematology ... eosinophils #diagnosis #management
Epley Maneuver for Treatment of BPPV

By Dr. Gutwein via @jmcchiefs

#Epley #Maneuver #BPPV #Benign #paroxysmal #positional #vertigo
Epley Maneuver for ... Treatment of BPPV ... Maneuver #BPPV #Benign ... #instructions #clinical ... #physicalexam #management
Von Willebrand Disease - Clinical Presentation, Diagnosis and Management

- Dr. Eric Strong @DrEricStrong - Strong Medicine
Willebrand Disease - Clinical ... Diagnosis and Management ... Disease #Diagnosis #Management ... #hematology #treatment
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... American College of Cardiology ... Task Force on Clinical ... #HeartFailure #Management ... #treatment #algorithm
Epley Maneuver for Treatment of BPPV
1) The patient begins in an upright sitting posture, and the
Epley Maneuver for ... Treatment of BPPV ... #BPPV #Benign # ... #instructions #clinical ... #physicalexam #management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology #treatment ... #decisionaid #cardiology ... #hematology #warfarin
Symptoms Distinguishing Groups of Cutaneous Drug Reactions
IgE-mediated reactions:
 • Onset minutes to hours into treatment course
to hours into treatment ... without scarring Benign ... Onset days into treatment ... Drug #Reactions #dermatology ... #clinical #comparison
Cor triatriatum
 • Epidemiology
 • Etiology
 • Associated Lesions
 • Differentials Diagnosis
 • Anatomy - Sinister,
Physiology • Clinical ... Diagnosis • Treatment ... Post-Operative Management ... CorTriatriatum #diagnosis #management ... #cardiology #summary
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
sometimes advanced treatment ... Treatments may include ... reserved for patients being ... #Management #Cardiology
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
#anesthesia #anesthesiology ... #treatment #algorithm ... Diagnosis and treatment ... Therapeutics and Clinical ... Risk Management